Nuvalent
Price & Volume
Stats
See moreOpen | $80.30 |
Previous Close | $81.08 |
Day Range | $80.30-$82.70 |
52W Range | $55.53-$106.32 |
Market Cap | $5.8B |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$4.92 |
News
See moreYahoo Finance • last month
Nuvalent’s SWOT analysis: oncology innovator’s stock faces pivotal year
Yahoo Finance • last month
Nuvalent to Present Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 Presidential Symposium
Yahoo Finance • 2 months ago
Nuvalent Inc-A (NASDAQ:NUVL) Reports Q2 2025 Earnings Miss with Focus on Oncology Pipeline Progress
Yahoo Finance • 2 months ago
Nuvalent initiates rolling NDA submission for ROS1-positive NSCLC drug
About
CFO | Ms. Alexandra Balcom CPA, M.B.A. |
Address | One Broadway, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 200 |
